Top Markets
Coin of the day
Cypherpunk Technologies Inc. Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc.

CYPH
Classifica tra le azioni #19170
Cypherpunk Technologies Inc. is a biopharmaceutical company dedicated to the... Cypherpunk Technologies Inc. is a biopharmaceutical company dedicated to the acquisition and development of antibody treatments for cancer. The firm's flagship investigational drug, DKN-01, is a monoclonal antibody designed to suppress Dickkopf-related protein 1 and is currently progressing through multiple clinical trials for various esophagogastric, gynecologic, and colorectal cancers. Additionally, the company is advancing FL-501, another monoclonal antibody that targets the GDF-15 protein, which is presently in preclinical development. Cypherpunk has established an agreement with Adimab, LLC and BeiGene, Ltd., granting it options and licenses to advance and market DKN-01 across Asia (excluding Japan), Australia, and New Zealand. Founded in 2011, the company operates from Cambridge, Massachusetts, and was formerly known as Leap Therapeutics, Inc. until its renaming in November 2025.
Prezzo delle azioni
$1.62
Ultima sincronizzazione: 2026-08-25
Capitalizzazione di mercato
$172.47M
Variazione (1 giorno)
-3.57%
Variazione (1 anno)
446.74%
Paese
US
Scambia Cypherpunk Technologies Inc. (CYPH)

Categoria

Cronologia dei frazionamenti azionari per Cypherpunk Technologies Inc. (CYPH)
L’azione Cypherpunk Technologies Inc. (simbolo: CYPH) ha subito un totale di 0 frazionamenti.
L’ultimo frazionamento è avvenuto il Aug 26, 2026.
Una quota di CYPH acquistata prima di Aug 26, 2026 equivale oggi a 0 quote di CYPH.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
Non abbastanza dati per le date fornite.
Frazionamenti azionari di aziende simili o concorrenti
Azienda Numero di frazionamenti azionari Moltiplicatore cumulativo Il paese
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH